Developing a Predictive Gene Classifier for Autism Spectrum Disorders Based upon Differential Gene Expression Profiles of Phenotypic Subgroups
Abstract
Autism spectrum disorders (ASD) are neurodevelopmental disorders which are currently diagnosed solely on the basis of abnormal stereotyped behavior as well as observable deficits in communication and social functioning. Although a variety of candidate genes have been identified on the basis of genetic analyses and up to 20% of ASD cases can be collectively associated with a genetic abnormality, no single gene or genetic variant is applicable to more than 1-2 percent of the general ASD population. In this report, we apply class prediction algorithms to gene expression profiles of lymphoblastoid cell lines (LCL) from several phenotypic subgroups of idiopathic autism defined by cluster analyses of behavioral severity scores on the Autism Diagnostic Interview-Revised diagnostic instrument for ASD. We further demonstrate that individuals from these ASD subgroups can be distinguished from nonautistic controls on the basis of limited sets of differentially expressed genes with a predicted classification accuracy of up to 94% and sensitivities and specificities of ~90% or better, based on support vector machine analyses with leave-one-out validation. Validation of a subset of the “classifier” genes by high-throughput quantitative nuclease protection assays with a new set of LCL samples derived from individuals in one of the phenotypic subgroups and from a new set of controls resulted in an overall class prediction accuracy of ~82%, with ~90% sensitivity and 75% specificity. Although additional validation with a larger cohort is needed, and effective clinical translation must include confirmation of the differentially expressed genes in primary cells from cases earlier in development, we suggest that such panels of genes, based on expression analyses of phenotypically more homogeneous subgroups of individuals with ASD, may be useful biomarkers for diagnosis of subtypes of idiopathic autism.
[N A J Med Sci. 2013;6(3):107-116. DOI: 10.7156/najms.2013.0603107]
Keywords
Full Text:
PDFReferences
American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders. IV ed. Washington, DC: American Psychological Association; 1994.
Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R. Genetics of autistic disorders: Review and clinical implications. Eur Child Adolesc Psychiatry. 2010;19(3):169-178.
Geschwind DH. Autism: Many genes, common pathways? Cell. 2008;135(3):391-395.
State MW, Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci. 2011;14(12):1499-1506.
Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68(11):1095-1102.
Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: Evidence from a british twin study. Psychol Med. 1995;25(1):63-77.
Folstein S, Rutter M. Infantile autism: A genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977;18(4):297-321.
Verkerk AJMH, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905-914.
Sutcliffe JS, Nelson DL, Zhang F, et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992;1(6):397-400.
Povey S, Burley MW, Attwood J, et al. Two loci for tuberous sclerosis: One on 9q34 and one on 16p13. Ann Hum Genet. 1994;58(2):107-127.
Jira PE, Waterham HR, Wanders RJA, Smeitink JAM, Sengers RCA, Wevers RA. Smith-lemli-opitz syndrome and the DHCR7 gene. Ann Hum Genet. 2003;67(3):269-280.
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23(2):185-188.
Van den Veyver IB, Zoghbi HY. Methyl-CpG-binding protein 2 mutations in rett syndrome. Curr Opin Genet Dev. 2000;10(3):275-279.
Hu VW, Steinberg ME. Novel clustering of items from the autism diagnostic interview-revised to define phenotypes within autism spectrum disorders. Autism Res. 2009;2(2):67-77.
Lord C, Rutter M, Couteur AL. Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659-685.
Hu VW, Sarachana T, Kim KS, et al. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: Evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009;2(2):78-97.
Hu VW, Frank BC, Heine S, Lee NH, Quackenbush J. Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics. 2006;7:118.
Saeed AI, Sharov V, White J, et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques. 2003;34(2):374-378.
Yeung KY, Bumgarner RE. Multiclass classification of microarray data with repeated measurements: Application to cancer. Genome Biol. 2003;4(12):R83.
Brown MPS, Grundy WN, Lin D, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A. 2000;97(1):262-267.
Roberts RA, Sabalos CM, LeBlanc ML, et al. Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma. Lab Invest. 2007;87(10):979-997.
Szabo ST, Machado-Vieira R, Yuan P, et al. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology. 2009;56(1):47-55.
Hasegawa H, Nakai M, Tanimukai S, et al. Microglial signaling by amyloid beta protein through mitogen-activated protein kinase mediating phosphorylation of MARCKS. Neuroreport 2001;12(11):2567-2571.
Sun YJ, Nishikawa K, Yuda H, et al. Solo/Trio8, a membrane-associated short isoform of trio, modulates endosome dynamics and neurite elongation. Mol Cell Biol. 2006;26(18):6923-6935.
Kong SW, Shimizu-Motohashi Y, Campbell MG, et al. Peripheral blood gene expression signature differentiates children with autism from unaffected siblings. Neurogenetics. 2013;14(2):143-152.
Belgard TG, Jankovic I, Lowe JK, Geschwind DH. Population structure confounds autism genetic classifier. Mol Psychiatry. 2013;1-3.
Skafidas E, Testa R, Zantomio D, Chana G, Everall IP, Pantelis C. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry. 2012;1-7.
Kong SW, Collins CD, Shimizu-Motohashi Y, et al. Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS ONE. 2012;7(12):e49475.
Glatt SJ, Tsuang MT, Winn M, et al. Blood-based gene expression signatures of infants and toddlers with autism. J Am Acad Child Adolesc Psychiatry. 2012;51(9):934-944.e2.
Refbacks
- There are currently no refbacks.